key: cord-0755980-tzkz2jzj authors: Svenningsen, Esben B.; Thyrsted, Jacob; Blay-Cadanet, Julia; Liu, Han; Lin, Shaoquan; Villameriel, Jaime Moyano; Olagnier, David; Idorn, Manja; Paludan, Søren R.; Holm, Christian K.; Poulsen, Thomas B. title: Ionophore antibiotic X-206 is a potent and selective inhibitor of SARS-CoV-2 infection in vitro date: 2020-06-25 journal: bioRxiv DOI: 10.1101/2020.06.14.149153 sha: 25599fb56cb73c4167e16efde3f705d07cfe6e1c doc_id: 755980 cord_uid: tzkz2jzj Pandemic spread of emerging human pathogenic viruses such as the current SARS-CoV-2, poses both an immediate and future challenge to human health and society. Currently, effective treatment of infection with SARS-CoV-2 is limited and broad spectrum antiviral therapies to meet other emerging pandemics are absent leaving the World population largely unprotected. Here, we have identified distinct members of the family of polyether ionophore antibiotics with potent ability to inhibit SARS-CoV-2 replication and cytopathogenicity in cells. Several compounds from this class displayed more than 100-fold selectivity between viral-induced cytopathogenicity and inhibition of cell viability, however the compound X-206 displayed >500-fold selectivity and was furthermore able to inhibit viral replication even at sub-nM levels. The antiviral mechanism of the polyether ionophores is currently not understood in detail. We demonstrate, through unbiased bioactivity profiling, that their effects on the host cells differ from those of cationic amphiphiles such as hydroxychloroquine. Collectively, our data suggest that polyether ionophore antibiotics should be subject to further investigations as potential broad-spectrum antiviral agents. The societal impact of the novel corona virus, SARS-CoV-2, that emerged in the end of 2019, 1,2 continues 37 to increase and the global death toll associated with the resulting respiratory disease, COVID19, is now 38 >400.000. The lack of effective antiviral therapies and long hospitalizations required for patients with severe 39 COVID19 threatens to overwhelm health care systems, which will continue to be risk until an effective 40 vaccine is developed or population immunity achieved. Given the long timeframes and uncertainties 41 involved in both of these scenarios attempts to repurpose compounds with available human safety data are 42 of high priority. Likewise, compounds, for which animal data is available, are of strong interest for 43 accelerated evaluation and development, in particular compounds that display broad-spectrum antiviral 44 activity or unusual modes-of-action. 3 The polyether ionophores is a family of natural products with diverse biological effects. CoV were however not reported. 11 The precise antiviral mechanism of the polyether ionophores is not 57 currently known, and earlier studies indicate that the compounds can interfere with several steps in the viral 58 replication cycle. 4, 8, 9 Here, we conduct a focused investigation on a series of polyether ionophores for their 59 ability to inhibit SARS-CoV-2 infection in vitro. We conducted an initial screen of 11 different naturally occurring polyether ionophores and one synthetic 64 analog for their ability to rescue the cytopathogenic effect (CPE) induced by SARS-CoV-2 viral infection of 65 Vero cells that overexpress the serine protease TMPRSS2. Viral infection produces a distinctive phenotype 66 of high fluorescence cells with condensed chromatin that was quantified by microscopy ( Figure 1A ). Interestingly, all 11 natural products display inhibitory activities in this assay although the potencies vary 68 significantly as do the selectivity indices (SI) to effects on cellular viability ( Figure 1B) . A subset, including 69 narasin, salinomycin, and nanchangmycin, display >100-fold selectivity while nigericin, indanomycin, 70 monensin, and lasalocid have slightly lower selectivities (50-100 fold). By contrast, the canonical Ca-71 ionophores ionomycin and calcimycin only show modest selectivity (5-and 18-fold). The synthetic polyether 72 ionophore HL-201, despite having potent antibacterial activity, 12 was unselective and scarcely active. We 73 were, however, especially intrigued to also identify compounds with strongly enhanced selectivity and Cationic amphiphiles, including hydroxychloroquine, are lysosomotropic agents that raise lysosomal pH and 90 can e.g. block autophagic processes. These effects, on the host cells, are believed to be directly involved in 91 the inhibitory activities against several types of viruses observed with many cationic amphiphiles. 15 Polyether ionophores have also been known to accumulate in lysosomes 16 and to inhibit autophagy 17 and 93 their canonical activity to facilitate exchange of metal cations for protons could also alter lysosomal pH. This experiment suggest that polyether ionophores mediate their antiviral effects through a mechanism that 105 is different from that of the lysosomotropic, cationic amphiphiles. The human safety data for polyether ionophores is -to the best of our knowledge -not known and these 108 compounds, including X-206, have toxicity in some animals. However, the fact that several members are A novel coronavirus from patients with pneumonia in China A new coronavirus associated with human respiratory disease in China Identification of SARS-CoV-2-mediated suppression of NRF2 signaling reveals a 220 potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate Polyether ionophores: broad-spectrum and promising 223 biologically active molecules for the control of drug-resistant bacteria and parasites Brzezinski Structures and properties of naturally occurring polyether antibiotics Forty years of monensin for the control of coccidiosis in 228 poultry Inhibitory effects of polyethers on human immunodeficiency virus replication Salinomycin inhibits influenza virus infection by disrupting endosomal acidification and viral 232 matrix protein 2 function Screening bioactives reveals nanchangmycin as a broad spectrum antiviral active 234 against zika virus Microbial aspects of polyether antibiotics: Activity, production, and biosynthesis Repurposing of clinically developed drugs for treatment of Middle East respiratory 239 syndrome coronavirus infection Diversity focused semisyntheses of tetronate polyether ionophores X-Ray crystal and molecular structure of antibiotic X-206 Potent antimalarial activities of polyether antibiotic, X-206 Antiviral activity of cationic amphiphilic drugs Salinomycin kills cancer stem cells by sequestering iron in lysosomes Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells 251 interferes with their maintenance Cell painting, a high-content image-based assay for morphological profiling using 253 multiplexed fluorescent dyes Suppression of influenza A virus replication in human lung epithelial cells by 255 noncytotoxic concentrations bafilomycin A1 Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs Establishing cell painting in a smaller chemical biology lab -A report 259 from the frontier